Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12
A Prospective, Randomized Study To Evaluate The Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12 Weeks
3 other identifiers
interventional
400
1 country
17
Brief Summary
Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Typical duration for not_applicable
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2022
CompletedFirst Posted
Study publicly available on registry
July 12, 2022
CompletedStudy Start
First participant enrolled
October 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 2, 2025
June 1, 2025
2.7 years
June 24, 2022
June 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of IPD patency
IPD patency without major complication
12 weeks post randomization
Secondary Outcomes (5)
Long-term rate of IPD patency in scheduled 4-week versus 12-week IPD flushes at 24,36 and 48 weeks post randomization.
Up to 48 weeks post randomization
Difference in complication rates in scheduled 4-week versus 12-week IPD flushes at 12, 24,36 and 48 weeks post randomization.
Up to 48 weeks post randomization
Difference in healthcare and patient cost in scheduled 4-week versus 12-week IPD flushes
Up to 48 weeks post randomization
Change in Participant Quality of Life and Satisfaction in Scheduled 4-week versus 12 week IPD flushes
Up to 48 weeks post randomization
Impact of smoking, participant age, IPD age, and concomitant medications on complication rates in scheduled 4-week versus 12 week IPD flushes.
Up to 48 weeks post randomization
Study Arms (2)
4-week IPD Flushing Schedule
ACTIVE COMPARATORIPD standard maintenance flushes and port assessments every 4 weeks.
12-week IPD Flushing Schedule
EXPERIMENTALIPD standard maintenance flushes and port assessments every 12 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Hematology/Oncology patients ≥ 18 years old with an Implanted Port Device.
- No planned clinical visits for at least 12 weeks.
- No planned need to access Implanted Port Device within next 12 weeks outside of routine flushing. Potential reasons to access can include but are not limited to lab draw, infusion, IV contrast.
- No planned removal of IPD within 12 weeks of registration.
- No Deep Vein Thrombosis or significant Implanted Port Device complication within ≤ 4 weeks of registration.
- Patient Implanted Port Device with documented blood return ≤ 14 days of registration.
- Ability to read and speak English.
- Able to give informed consent.
You may not qualify if:
- Allergy to heparin
- Vulnerable populations: pregnant women, prisoners, mentally handicapped.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Essentia Healthlead
- Minnesota Cancer Clinical Trials Networkcollaborator
Study Sites (17)
Mayo Clinic Health System - Albert Lea
Albert Lea, Minnesota, 56007, United States
Essentia Health St. Joseph's Medical Center
Brainerd, Minnesota, 56401, United States
Essentia Health Deer River Clinic
Deer River, Minnesota, 56636, United States
Essentia Health St Mary's Detroit Lakes Clinic
Detroit Lakes, Minnesota, 56501, United States
Essentia Health Duluth Clinic
Duluth, Minnesota, 55805, United States
Essentia Health Fosston
Fosston, Minnesota, 56542, United States
Fairview Grand Itasca Clinic & Hospital
Grand Rapids, Minnesota, 55744, United States
Essentia Health Hibbing Clinic
Hibbing, Minnesota, 55746, United States
Fairview Range Medical Center
Hibbing, Minnesota, 55746, United States
Mayo Clinic Health System - Mankato
Mankato, Minnesota, 56001, United States
Monticello Cancer center
Monticello, Minnesota, 55362, United States
Essentia Health Park Rapids
Park Rapids, Minnesota, 56470, United States
Fairview Northland Medical Center
Princeton, Minnesota, 55371, United States
Essentia Health Sandstone
Sandstone, Minnesota, 55072, United States
Essentia Health Virginia Clinic
Virginia, Minnesota, 55792, United States
Sanford Worthington Medical Center
Worthington, Minnesota, 56187, United States
Essentia Health Fargo
Fargo, North Dakota, 58103, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Bret Friday, MD, PhD
Essentia Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2022
First Posted
July 12, 2022
Study Start
October 11, 2022
Primary Completion
July 1, 2025
Study Completion
December 31, 2025
Last Updated
July 2, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 6 months after study completion and for 36 months
- Access Criteria
- A full description of the intended use of the data must be sent to the Project Direct for review and approval. Participant consent for data sharing is conditioned and new ethics approval may be required.
The study protocol, statistical plan and consent form will be available on request. Data will be available on aggregate level; data will be deidentified, the full dataset and statistical code will be available upon request